Results 1-7 of 7 (Search time: 0.006 seconds).

Issue DateTitleAuthor(s)SourcescopusWOSFulltext/Archive link
12016Activation of salt-inducible kinase 2 promotes the viability of peritoneal mesothelial cells exposed to stress of peritoneal dialysisWang, H-H; Lin, C-Y; Su, S-H; Chuang, C-T; Chang, Y-L; Lee, T-Y; Lee, S-C; Chang, C-J; 呂勝春Cell Death and Disease 33
22014Bortezomib enhances cancer cell death by blocking the autophagic flux through stimulating ERK phosphorylationKao, C.; Chao, A.; Tsai, C.-L.; Chuang, W.-C.; Huang, W.-P.; Chen, G.-C.; Lin, C.-Y.; Wang, T.-H.; Wang, H.-S.; Lai, C.-H.; WEI-PANG HUANG Cell Death and Disease 7075
32014CBAP promotes thymocyte negative selection by facilitating T-cell receptor proximal signalingHo, K-C; Chiang, Y-J; Lai, A. C-Y; Liao, N-S; Chang, Y-J; Yang-Yen, H-F; Yen, J. J-YCell Death and Disease 34
42014Erlotinib derivative inhibits hepatocellular carcinoma by targeting CIP2A to reactivate protein phosphatase 2AKuen-Feng Chen Cell Death and Disease 4241
52018Mitochondrial Lon sequesters and stabilizes p53 in the matrix to restrain apoptosis under oxidative stress via its chaperone activitySung, Y.-J.; CHUN-HUA HSU et al. Cell Death and Disease 2725
62014Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinibCHE-MING TENGCell Death and Disease 1716
72013The HDAC inhibitor, MPT0E028, enhances erlotinib-induced cell death in EGFR-TKI-resistant NSCLC cellsCHE-MING TENG Cell Death and Disease 6459